Khedezla (Desvenlafaxine Extended-release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 22, 2013 Category: Drugs & Pharmacology Source Type: news
Meds Don't Help Anymore
Tortoiseshell on our forum asked the following question:
I feel it is time for me to change meds or add something to the current meds.
I am currently on Pristiq 100mg/day and Lamictal 200 mg/day. Increasing the dose didn't help, but worsened the side effects. These meds worked relatively well for me for 3 years until last September I had very emotionally difficult situation and got into destructive relationship. It threw me back again. Since then I haven't been able to enjoy myself and life despite of going to counseling weekly. Just not getting better.
I am seeing my psychiatrist next week. She is very flexi...
Source: About.com Depression - May 30, 2013 Category: Psychiatry Source Type: news
Nonhormonal Option for Hot Flashes: Good NewsNonhormonal Option for Hot Flashes: Good News
JoAnn Manson discusses 3 studies on desvenlafaxine for menopausal vasomotor symptoms and concludes that the news is good. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news
Topline Phase 4 Results for SNRI ReleasedTopline Phase 4 Results for SNRI Released
Results from a large phase 4 study shows efficacy for desvenlafaxine 50 mg/day and 100 mg/day doses compared with placebo for the treatment of adult major depression. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 24, 2013 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Desvenlafaxine Safely Curbs Hot FlushesDesvenlafaxine Safely Curbs Hot Flushes
Desvenlafaxine (Pristiq, Pfizer) maintains its efficacy in reducing menopausal vasomotor symptoms and does so safely, according to two reports online December 24 in Menopause. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 4, 2013 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news
Desvenlafaxine safely curbs hot flushes
NEW YORK (Reuters Health) - Desvenlafaxine (Pristiq, Pfizer) maintains its efficacy in reducing
menopausal vasomotor symptoms and does so safely, according to two reports online December 24 in
Menopause. (Source: Modern Medicine)
Source: Modern Medicine - January 4, 2013 Category: Journals (General) Source Type: news
